Journal of Antimicrobial Chemotherapy (2002) 50, 313-321
© 2002 The British Society for Antimicrobial Chemotherapy
Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101
1 School of Biomedical Sciences and Gram-positive Bacteria Typing and Research Unit, Curtin University of Technology, Perth 6845, Western Australia, Australia; 2 Microbiology Department, College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA
Received 7 March 2002; returned 7 May 2002; revised 14 June 2002; accepted 20 June 2002
We report the cloning of the fusidic acid and cadmium resistance determinants from Staphylococcus aureus plasmid pUB101. The pUB101 fusidic acid resistance determinant was located on a 2.9 kb HindIII fragment. Sequencing of this fragment revealed three putative open reading frames (ORFs) of 213 (far1), 152 (orf152) and 170 amino acids (orf170), which are flanked by the right-hand end of insertion sequence IS431/257 (IS431/257RH) and a partial ORF. Far1 and Orf152 demonstrated homology with a chromosomally encoded fibronectin-binding protein of Listeria monocytogenes and the putative protein YosT, found on the SPßc2 prophage of Bacillus subtilis, respectively. Transformation of S. aureus with a construct containing a 949 bp far1-specific amplicon led to the isolation of a fusidic acid-resistant transformant, thereby identifying the pUB101 fusidic acid resistance structural gene. Between orf152 and far1 we identified a unique 113 bp symmetrical element and other repeat elements that may be involved with the control of orf152 and/or far1 expression. Hybridization of Southern blots revealed that far1 was not located on the chromosome or plasmid content of a limited number of Australian, UK and Hong Kong fusidic acid-resistant isolates. The pUB101 cadmium resistance determinant was located on a 3.6 kb HindIII fragment that carried a cadDX operon, remnants of two putative plasmid replication protein genes and IS431/257RH. Sequence analysis also demonstrated the presence of a single-stranded origin of replication, normally found on rolling circle replicating plasmids, within the putative promoter region of the cadDX operon.
* Correspondence address. Department of Biology MSC 3AF, New Mexico State University, PO Box 30001, Las Cruces, NM 88003-8001, USA. Tel: +1-505-646-3611; Fax: +1-505-646-5660; E-mail: jgustafs{at}nmsu.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Lannergard, T. Norstrom, and D. Hughes Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2059 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Delgado, S. Zaman, A. Muthaiyan, V. Nagarajan, M. O. Elasri, B. J. Wilkinson, and J. E. Gustafson The fusidic acid stimulon of Staphylococcus aureus J. Antimicrob. Chemother., December 1, 2008; 62(6): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kwong, R. Lim, R. J. LeBard, R. A. Skurray, and N. Firth Analysis of the pSK1 replicon, a prototype from the staphylococcal multiresistance plasmid family Microbiology, October 1, 2008; 154(10): 3084 - 3094. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. M. Chen, C. W. Feng, C. F. Chiu, and R. A. Burne cadDX Operon of Streptococcus salivarius 57.I Appl. Envir. Microbiol., March 1, 2008; 74(5): 1642 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Norstrom, J. Lannergard, and D. Hughes Genetic and Phenotypic Identification of Fusidic Acid-Resistant Mutants with the Small-Colony-Variant Phenotype in Staphylococcus aureus Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4438 - 4446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Yazdankhah, A. W. Asli, H. Sorum, H. Oppegaard, and M. Sunde Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci J. Antimicrob. Chemother., December 1, 2006; 58(6): 1254 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Besier, A. Ludwig, V. Brade, and T. A. Wichelhaus Compensatory Adaptation to the Loss of Biological Fitness Associated with Acquisition of Fusidic Acid Resistance in Staphylococcus aureus Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1426 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. O'Neill, A. R. Larsen, A. S. Henriksen, and I. Chopra A Fusidic Acid-Resistant Epidemic Strain of Staphylococcus aureus Carries the fusB Determinant, whereas fusA Mutations Are Prevalent in Other Resistant Isolates Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3594 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. G. Holden, E. J. Feil, J. A. Lindsay, S. J. Peacock, N. P. J. Day, M. C. Enright, T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, et al. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance PNAS, June 29, 2004; 101(26): 9786 - 9791. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Dobie and J Gray Fusidic acid resistance in Staphylococcus aureus Arch. Dis. Child., January 1, 2004; 89(1): 74 - 77. [Abstract] [Full Text] [PDF] |
||||





